Tafluprost-Timolol Fixed Dose Combination Non-Inferiority Study Against Concomitant Administrations

Inclusion Criteria: * Aged 18 years or more * A diagnosis of ocular hypertension or open-angle glaucoma * Meet specific IOP level at visit 1 (screening)and visit 2 (baseline) * Meet specific visual acuity score * Are willing to follow instructions * Have provided a written informed consent Exclusion Criteria: * Females who are pregnant, nursing or planning pregnancy * IOP greater than 36 mmHg at any time point at screening or baseline * Diagnosis of angle-closure glaucoma or secondary glaucoma other than capsular or pigmentary glaucoma in either eye * Suspected contraindication or hypersensitivity to study medications tafluprost or timolol (e.g. asthma, low pulse) or to wash-out medication brinzolamide * Glaucoma filtration surgery or any other ocular surgery (including ocular laser procedures) within 6 months prior to Screening * Use of contact lenses at Screening or during the study * Presence of any abnormality or significant illness that could be expected to interfere with the patient safety or study parameters * Current participation in another clinical trial within the last 30 days